SEC Form 4 · accession 0000939767-16-000272

EXELIXIS, INC. · EXEL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — EVP, Scientific Strategy & CSO

Period of report

Nov 9, 2016

Accepted (ET)

Nov 14, 2016 · 7:34 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000939767

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Nov 9, 2016	M	50,000	$5.04	A	123,600	D
Common Stock	Nov 9, 2016	M	20,000	$5.50	A	143,600	D
Common Stock	Nov 9, 2016	S	70,000	$13.15	D	73,600	D
Common Stock^F3	holding	—	—		—	16,024	I	By 401(k)

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Option (right to buy)^F4	$5.04	Nov 9, 2016	M	50,000	D	Dec 16, 2009	Dec 15, 2018	Common Stock	50,000	0	D
Option (right to buy)^F5	$5.50	Nov 9, 2016	M	20,000	D	Sep 28, 2012	Sep 27, 2018	Common Stock	20,000	55,000	D

F1Includes 16,250 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
F2The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2016.
F3Represents 16,024 shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of November 9, 2016.
F4The option, representing the right to purchase a total of 50,000 shares of Exelixis, Inc. common stock, became fully exercisable on December 16, 2012.
F5The option, representing the right to purchase a total of 75,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 28, 2015.